Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway. [electronic resource]
Producer: 20150102Description: 17-24 p. digitalISSN:- 1522-9629
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Animals
- Benzimidazoles -- pharmacology
- Benzoates -- pharmacology
- Disease Models, Animal
- Endothelium, Vascular -- drug effects
- Hypertension, Pulmonary -- drug therapy
- Male
- Monocrotaline -- toxicity
- Nitric Oxide Synthase Type III -- metabolism
- PPAR gamma -- metabolism
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphorylation -- drug effects
- Proto-Oncogene Proteins c-akt -- metabolism
- Pulmonary Artery -- drug effects
- Rats
- Rats, Sprague-Dawley
- Signal Transduction -- drug effects
- Telmisartan
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.